Table 4.
Patient no |
Sex | Age | Pre-treatment CD4 count (cell/µL |
Pre-treatment HIV-RNA(viral load) copies/ml |
Post-treatment CD4 count (cell/µL) |
Post-treatment HIV-RNA(viral load) copies/ml |
A-zam or HAART or both |
Increase in CD4 count |
12/z | M | 29 | 187±10.4 | 49000±574.5 | 820±53.9 | undetectable | both | 633±30.8 |
01/OS | M | 25 | 137±7.3 | 52000±486.1 | 760±32.7 | undetectable | A-zam | 623±40 |
01/z | F | 7 | 137±7.3 | 51000±132 | 760±32.7 | undetectable | A-zam | 623±40 |
08/z | M | 46 | 140±6.2 | 53000±839.7 | 750±29.2 | undetectable | A-zam | 610±35.4 |
04/Z | M | 28 | 192±12.2 | 50000±221 | 780±39.8 | undetectable | both | 588±27.6 |
21/OS | F | 31 | 178±7.2 | 50000±221 | 570±34.5 | undetectable | A-zam | 392±41.7 |
09/z | M | 42 | 140±6.2 | 51000±132.6 | 450±76.9 | <500 | A-zam | 310±70.7 |
06/OS | M | 37 | 150±2.7 | 49000±574.5 | 450±76.9 | <1000 | both | 300±74.2 |
Mean | 4 | 30.6 | 157.6±7.4 | 50625±397.7 | 667.5±47 | variable | 509.9±36 |